Cargando…

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis

The prognostic role of baseline C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) is controversial. In order to clarify this issue, we performed a systematic review and meta-analysis to assess the predictive effect of baseline CRP level in COPD patients. 15 eligible articles f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leuzzi, Giovanni, Galeone, Carlotta, Taverna, Francesca, Suatoni, Paola, Morelli, Daniele, Pastorino, Ugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488765/ https://www.ncbi.nlm.nih.gov/pubmed/28143876 http://dx.doi.org/10.1183/16000617.0070-2016

Ejemplares similares

Effect of Tobacco Smoking Cessation on C-Reactive Protein Levels in A Cohort of Low-Dose Computed Tomography Screening Participants
por: Gallus, Silvano, et al.
Publicado: (2018)

Inflammatory status and lung function predict mortality in lung cancer screening participants
por: Pastorino, Ugo, et al.
Publicado: (2018)

Evaluation of Simplified Diet Scores Related to C-Reactive Protein in Heavy Smokers Undergoing Lung Cancer Screening
por: Sabia, Federica, et al.
Publicado: (2022)

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
por: Sestini, Stefano, et al.
Publicado: (2015)

Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
por: Sestini, Stefano, et al.
Publicado: (2019)

Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling
por: Petraroia, Ilaria, et al.
Publicado: (2023)

Routine perioperative blood tests predict survival of resectable lung cancer
por: Morelli, Daniele, et al.
Publicado: (2023)

Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality
por: Silva, Mario, et al.
Publicado: (2017)

Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR
por: Conte, Davide, et al.
Publicado: (2015)

Catching a shark while looking for flounders
por: Orlandi, Riccardo, et al.
Publicado: (2023)

Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients
por: Fortunato, Orazio, et al.
Publicado: (2014)

Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting
por: Montomoli, Emanuele, et al.
Publicado: (2021)

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
por: Mensah, Mavis, et al.
Publicado: (2017)

COPD assessment test score and serum C-reactive protein levels in stable COPD patients
por: Kang, Hyung Koo, et al.
Publicado: (2016)

Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320
por: Pontis, Francesca, et al.
Publicado: (2021)

Feasibility and Safety of Lung Cancer Screening and Prevention Program During the COVID-19 Pandemic
por: Milanese, Gianluca, et al.
Publicado: (2021)

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
por: Fortunato, Orazio, et al.
Publicado: (2022)

C-reactive protein levels in stable COPD patients: a case-control study
por: Silva, Denise Rossato, et al.
Publicado: (2015)

Testing of human papillomavirus in lung cancer and non-tumor lung tissue
por: Galvan, Antonella, et al.
Publicado: (2012)

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers
por: Verri, Carla, et al.
Publicado: (2017)

Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure
por: Pastorino, Ugo, et al.
Publicado: (2021)

Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis
por: Milione, Massimo, et al.
Publicado: (2020)

Are interstitial lung abnormalities associated with COPD? A nested case–control study
por: Bozzetti, Francesca, et al.
Publicado: (2016)

C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations: A protocol for systematic review and meta-analysis
por: An, Xing, et al.
Publicado: (2020)

Levels of physical activity and predictors of mortality in COPD
por: Nyssen, Samantha Maria, et al.
Publicado: (2013)

Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling
por: Di Paolo, Daniela, et al.
Publicado: (2021)

Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification
por: Lin, Yi-Hua, et al.
Publicado: (2016)

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy
por: Apolone, Giovanni, et al.
Publicado: (2020)

Glycemic Index, Glycemic Load and Cancer Risk: An Updated Meta-Analysis
por: Turati, Federica, et al.
Publicado: (2019)

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
por: Moro, Massimo, et al.
Publicado: (2018)

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
por: Moro, Massimo, et al.
Publicado: (2017)

Beta-blocker use and COPD mortality: a systematic review and meta-analysis
por: Etminan, Mahyar, et al.
Publicado: (2012)

Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD
por: Francis, Nick A, et al.
Publicado: (2020)

Long term outcome of complex surgical resection and reconstruction for rare thoracic cancers
por: Pastorino, Ugo, et al.
Publicado: (2023)

Coffee Consumption and C-Reactive Protein Levels: A Systematic Review and Meta-Analysis
por: Moua, Elizabeth D., et al.
Publicado: (2020)

Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
por: Halpin, David M G, et al.
Publicado: (2022)

Time to market access in Italia: durata del processo di P&R per i farmaci per le malattie rare
por: Marcellusi, Andrea, et al.
Publicado: (2023)

Meta-analysis of routine blood tests as predictors of mortality in COPD
por: Lomholt, Frederikke K., et al.
Publicado: (2014)

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2020)

The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency
por: Jommi, Claudio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4j1r860gu1jq73n79s919rbk1d